Vanguard Personalized Indexing Management, LLC Vertex Pharmaceuticals Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 31,178 shares of VRTX stock, worth $14.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
31,178
Previous 31,797
1.95%
Holding current value
$14.1 Million
Previous $14.8 Million
15.1%
% of portfolio
0.19%
Previous 0.24%
Shares
21 transactions
Others Institutions Holding VRTX
# of Institutions
1,728Shares Held
223MCall Options Held
1.65MPut Options Held
1.38M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.66 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.36 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.08 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...